Fertility preservation in women with vasculitis: Experiences from the fertiprotekt network

Clinical and Experimental Rheumatology

Volumn 30, Issue SUPPL. 70, 2012, Pages

  Henes, Joerg C ^a,d   Henes, Melanie ^b,d   von Wolff, Michael ^c,d   Schmalzing, Marc ^a,d   Kötter, Ina ^a,d   Lawrenz, Barbara ^b,d  

^a Centre for Interdisciplinary Clinical Immunology Rheumatology and Autoimmune Diseases   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c Universitats Frauenklinik   (Switzerland)

^d Centres of the Ferti PROTEKT Network   (Germany)

Author keywords

Autoimmune disease; Cyclophosphamide; Fertility preservation; Fertiprotect; Vasculitis

Indexed keywords

GONADORELIN DERIVATIVE;

ADOLESCENT; ADULT; ANCA ASSOCIATED VASCULITIS; AORTA ARCH SYNDROME; ARTICLE; AUTOIMMUNE DISEASE; CLINICAL ARTICLE; CRYOPRESERVATION; DISEASE ASSOCIATION; DISEASE REGISTRY; FEMALE; FEMALE FERTILITY; FERTIPROTEKT NETWORK; HUMAN; INFORMATION PROCESSING; OOCYTE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REPRODUCTIVE PROCEDURE; VASCULITIS;

ADULT; COUNSELING; CRYOPRESERVATION; CYCLOPHOSPHAMIDE; EUROPE; FEMALE; FERTILITY; FERTILITY AGENTS, FEMALE; FERTILITY PRESERVATION; GONADOTROPIN-RELEASING HORMONE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFERTILITY, FEMALE; OVARY; OVULATION INDUCTION; PARITY; PREGNANCY; REGISTRIES; VASCULITIS; YOUNG ADULT;

EID: 84863738076     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. DE MENTHON M, MAHR A: Treating polyarteritis nodosa: current state of the art. Clin Exp Rheumatol 2011; 29 (Suppl. 64): 110-6.
2. BOUMPAS DT, AUSTIN HA 3RD, VAUGHAN EM YARBORO CH, KLIPPEL JH, BALOW JE: Risk for sustained amenorrhea in patients with systemic lupus erythematosus receiving intermittent pulse cyclophosphamide therapy. Ann Intern Med 1993; 119: 366-9.
3. MCDERMOTT EM, POWELL RJ: Incidence of ovarian failure in systemic lupus erythematosus after treatment with pulse cyclophosphamide. Ann Rheum Dis 1996; 55: 224-9.
4. CLOWSE ME, COPLAND SC, HSIEH TC et al.: Ovarian reserve diminished by oral cyclophosphamide therapy for granulomatosis with polyangiitis (Wegener's). Arthritis Care Res (Hoboken). 2011; 63: 1777-81.
5. VON WOLFF M, MONTAG M, DITTRICH R, DENSCHLAG D, NAWROTH F, LAWRENZ B: Fertility preservation in women-a practical guide to preservation techniques and therapeutic strategies in breast cancer, Hodgkin's lymphoma and borderline ovarian tumours by the fertility preservation network Ferti-PROTEKT. Arch Gynecol Obstet 2011; 284: 427-35.
6. LAWRENZ B, HENES JC, HENES M et al.: Impact of systemic lupus erythematosus on ovarian reserve in premenopausal women: Evaluation by using anti-Muellerian hormone. Lupus 2011; 20: 1193-7.
7. BEN-AHARON I, GAFTER-GVILI A, LEIBOVICI L STEMMER SM: Pharmacological interventions for fertility preservation during chemotherapy: a systematic review and metaanalysis. Breast Cancer Res Treat 2010; 122: 803-11.
8. CLOWSE M, BEHERA MA, ANDERS CK et al.: Ovarian preservation by GnRH agonists during chemotherapy: a meta-analysis. J Women's Health 2009; 18: 311-9.
9. TUIN J, SANDERS JS, DE JOODE AA, STEGEMAN CA: Pregnancy in women diagnosed with ANCA-associated vasculitis: favorable outcome for mother and child. Arthritis Care Res (Hoboken). Epub 2011 Dec 12.
10. PAGNOUX C, LE GUERN V, GOFFINET F et al.: Pregnancies in systemic necrotizing vasculitides: report on 12 women and their 20 pregnancies. Rheumatology (Oxford) 2011; 50: 953-61.
11. ISHIKAWA K, MATSUURA S: Occlusive thromboaortopathy (Takayasu's disease) and pregnancy. Clinical course and management of 33 pregnancies and deliveries. Am J Cardiol 1982; 50: 1293-300.
12. JADAON J, SHUSHAN A, EZRA Y et al.: Behçet disease and pregnancy. Acta Obstet Gynecol Scand 2005; 84: 939-44.
13. UZUN S, ALPSOY E, DURDU M, AKMAN A: pregnancy: a retrospective analysis and review of the literature. J Dermatol 2003; 30: 499-502.
14. DONNEZ J, DOLMANS MM: Preservation of fertility in females with haematological malignancy. Br J Haematol 2011 54: 175-84.
15. DITTRICH R, LOTZ L, KECK G et al.: Live birth after ovarian tissue autotransplantation following overnight transportation before cryopreservation. Fertil Steril Epub 2011 Dec 16.
16. JONES RB, TERVAERT JW, HAUSER T et al.: European vasculitis Study Group. Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis. N Engl J Med 2010; 363: 211-20.
17. HELLMICH B: Update on the management of systemic vasculitis: what did we learn in 2009? Clin Exp Rheumatol 2010; 28 (Suppl. 57): 98-103.
18. LASKARI K, ZINTZARAS E, TZIOUFAS AG: Ovarian function is preserved in women with severe systemic lupus erythematosus after a 6-month course of cyclophosphamide followed by mycophenolate mofetil. Clin Exp Rheumatol 2010; 28: 83-6.